Quick Answer
XORTX Therapeutics Inc. reported Total Assets of $2.68 million for fiscal year 2025.
XORTX Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $2.68M | -34.5% |
| 2024 | $4.09M | -25.1% |
| 2023 | $5.47M | -55.8% |
| 2022 | $12.37M | -28.8% |
| 2021 | $17.38M | +658.9% |
| 2020 | $2.29M | — |
- XORTX Therapeutics Inc. showed a decrease of -34.5% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, XORTX Therapeutics Inc.’s total assets has grown by 17.2% (from $2.29 million to $2.68 million).
- The most recent figure is from XORTX Therapeutics Inc.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: